The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
First-line FOLFIRI and bevacizumab in patients with advanced colorectal cancer prospectively stratified according to serum LDH: Final results of the Italian Research Group for Digestive Tract Cancer (GISCAD) CENTRAL (ColorEctalvastiNTRiAlLdh) and SENTRAL (Serum angiogenesis-cENTRAL) analysis.
 
Mario Scartozzi
No Relationships to Disclose
 
Riccardo Giampieri
No Relationships to Disclose
 
Bruno Daniele
No Relationships to Disclose
 
Daris Ferrari
No Relationships to Disclose
 
Sara Lonardi
No Relationships to Disclose
 
Alberto Zaniboni
No Relationships to Disclose
 
Luigi Cavanna
No Relationships to Disclose
 
Gerardo Rosati
No Relationships to Disclose
 
Nicoletta Pella
No Relationships to Disclose
 
M. Giulia Zampino
No Relationships to Disclose
 
Pietro Sozzi
No Relationships to Disclose
 
Laura Casula
No Relationships to Disclose
 
Lorena Cozzi
No Relationships to Disclose
 
Domenico Germano
No Relationships to Disclose
 
Marco Puzzoni
No Relationships to Disclose
 
Cristian Loretelli
No Relationships to Disclose
 
Vittorina Zagonel
No Relationships to Disclose
 
Roberto Labianca
No Relationships to Disclose
 
Luciano Frontini
No Relationships to Disclose
 
Stefano Cascinu
No Relationships to Disclose